Mirion Technologies (NYSE:MIR – Free Report) had its target price cut by Citigroup from $29.00 to $28.00 in a research report released on Thursday,Benzinga reports. They currently have a buy rating on the stock.
Several other brokerages have also recently commented on MIR. JPMorgan Chase & Co. dropped their target price on shares of Mirion Technologies from $30.00 to $27.00 and set an “overweight” rating for the company in a research report on Thursday, March 26th. Melius Research raised Mirion Technologies to a “strong-buy” rating in a research note on Monday, March 23rd. The Goldman Sachs Group decreased their target price on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Robert W. Baird cut their price target on shares of Mirion Technologies from $29.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, March 30th. Finally, Morgan Stanley reduced their price objective on shares of Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 11th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Mirion Technologies has a consensus rating of “Moderate Buy” and an average price target of $27.13.
Check Out Our Latest Stock Report on Mirion Technologies
Mirion Technologies Stock Up 5.7%
Mirion Technologies (NYSE:MIR – Get Free Report) last released its earnings results on Tuesday, April 28th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. The company had revenue of $257.60 million for the quarter, compared to the consensus estimate of $244.78 million. Mirion Technologies had a net margin of 2.56% and a return on equity of 6.44%. The company’s revenue was up 27.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.10 EPS. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. On average, equities research analysts forecast that Mirion Technologies will post 0.51 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the company. Royal Bank of Canada lifted its stake in Mirion Technologies by 258.2% in the 1st quarter. Royal Bank of Canada now owns 98,828 shares of the company’s stock valued at $1,433,000 after purchasing an additional 71,241 shares during the last quarter. AQR Capital Management LLC raised its stake in Mirion Technologies by 124.3% in the first quarter. AQR Capital Management LLC now owns 199,211 shares of the company’s stock valued at $2,889,000 after buying an additional 110,399 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Mirion Technologies by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 122,962 shares of the company’s stock valued at $1,783,000 after buying an additional 5,366 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Mirion Technologies by 8.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 434,583 shares of the company’s stock worth $6,301,000 after purchasing an additional 34,973 shares during the period. Finally, Cetera Investment Advisers acquired a new position in shares of Mirion Technologies in the second quarter valued at $288,000. 78.51% of the stock is currently owned by institutional investors and hedge funds.
Mirion Technologies Company Profile
Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.
Further Reading
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
